France has created temporary guidelines allowing CBD companies to register their products as food supplements pending authorisation under the EU’s upcoming novel foods regulation.
But the change does not mean the products can be legally sold in France – as has been reported – since no cannabinoid ingredient has yet been granted novel food authorisation.
This article was written by one of CannIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual cannabis and cannabinoid markets. For a full list, please see our Who We Are page.
Our Key Benefits
The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.
CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.
Stay informed of any legal and market change in the sector that impacts your organisation
Maximise resources by getting market and legal data analysis daily in one place
Make smart decisions by understanding how the regulatory and market landscape evolves
Anticipate risks in your decisions by monitoring regulatory changes that impact your organization
Want the full analysis? Let's talk
We share insights with professionals we’re in contact with. Let us know a bit about your interest.
LATEST ALERTS
